Short Communication
Mohammed Saeed Al-Ismail
Abstract
Community-acquired pneumonia (CAP) - The infectious disease - remains a worldwide health problem with a high rate of morbidity and mortality. Identification of microbial pathogens which cause pneumonia is an important area for optimum clinical management of pneumonia patients. Several scoring system have been developed to predict Community-acquired pneumonia (CAP) mortality risk and serve as guides for admission into the reqular ward and the intensive care unit. After about 12 years a joint update of the Commuinty-acquired Pneumonia (CAP) guidelines which was recently published by the Infectious Diseases Society of America/ American Thoracic Society This presentation aimed to review the current diagnostic and managment tools used for Community acquired pneumonia (CAP), highlight those potentially applicable in adults with CAP and highlights some key updates to the antimicrobial therapy recommendations. Patients hospitalized with pneumonia often receive excess antibiotic therapy. Excess antibiotic treatment was associated with patient-reported adverse events. Future interventions should focus on whether reducing excess treatment and improving documentation at discharge improves outcomes.